A proposed deal for Purdue Pharma LP to resolve more than 2,000 lawsuits over its role in the opioid crisis is facing pushback from a vocal group of state attorneys general who say it doesn’t bring in enough cash to satisfy their demands, according to people familiar with the matter.
from MarketWatch.com - Top Stories https://ift.tt/2NL2XoR
Friday, August 30, 2019
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment